Zunino F - Search Results

1

Development of resistance to the atypical retinoid, ST1926, in the lung carcinoma cell line H460 is associated with reduced formation of DNA strand breaks and a defective DNA damage response.

Zuco V, Zanchi C, Lanzi C, Beretta GL, Supino R, Pisano C, Barbarino M, Zanier R, Bucci F, Aulicino C, Carminati P, Zunino F. Zuco V, et al. Among authors: zunino f. Neoplasia. 2005 Jul;7(7):667-77. doi: 10.1593/neo.05127. Neoplasia. 2005. PMID: 16026646 Free PMC article.

2

Cellular bases of the antitumor activity of a 7-substituted camptothecin in hormone-refractory human prostate carcinoma models.

Zuco V, Supino R, De Cesare M, Carenini N, Perego P, Gatti L, Pratesi G, Pisano C, Martinelli R, Bucci F, Zanier R, Carminati P, Zunino F. Zuco V, et al. Among authors: zunino f. Biochem Pharmacol. 2003 Apr 15;65(8):1281-94. doi: 10.1016/s0006-2952(03)00079-0. Biochem Pharmacol. 2003. PMID: 12694869

3

Modulation of survival signaling pathways and persistence of the genotoxic stress as a basis for the synergistic interaction between the atypical retinoid ST1926 and the epidermal growth factor receptor inhibitor ZD1839.

Zanchi C, Zuco V, Lanzi C, Supino R, Zunino F. Zanchi C, et al. Among authors: zunino f. Cancer Res. 2005 Mar 15;65(6):2364-72. doi: 10.1158/0008-5472.CAN-04-2495. Cancer Res. 2005. PMID: 15781651

4

Cyclic pifithrin-alpha sensitizes wild type p53 tumor cells to antimicrotubule agent-induced apoptosis.

Zuco V, Zunino F. Zuco V, et al. Among authors: zunino f. Neoplasia. 2008 Jun;10(6):587-96. doi: 10.1593/neo.08262. Neoplasia. 2008. PMID: 18516295 Free PMC article.

5

Sensitization of ovarian carcinoma cells to the atypical retinoid ST1926 by the histone deacetylase inhibitor, RC307: enhanced DNA damage response.

Zuco V, Benedetti V, De Cesare M, Zunino F. Zuco V, et al. Among authors: zunino f. Int J Cancer. 2010 Mar 1;126(5):1246-55. doi: 10.1002/ijc.24819. Int J Cancer. 2010. PMID: 19676051

6

Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoid.

Zuco V, Zanchi C, Cassinelli G, Lanzi C, Supino R, Pisano C, Zanier R, Giordano V, Garattini E, Zunino F. Zuco V, et al. Among authors: zunino f. Cell Death Differ. 2004 Mar;11(3):280-9. doi: 10.1038/sj.cdd.4401304. Cell Death Differ. 2004. PMID: 14657960

7

Cellular bases of the antitumor activity of the novel taxane IDN 5109 (BAY59-8862) on hormone-refractory prostate cancer.

Cassinelli G, Lanzi C, Supino R, Pratesi G, Zuco V, Laccabue D, Cuccuru G, Bombardelli E, Zunino F. Cassinelli G, et al. Among authors: zunino f. Clin Cancer Res. 2002 Aug;8(8):2647-54. Clin Cancer Res. 2002. PMID: 12171897

8

Electron microscopy analysis of early localization of cisplatin in ovarian carcinoma cells.

Beretta GL, Righetti SC, Lombardi L, Zunino F, Perego P. Beretta GL, et al. Among authors: zunino f. Ultrastruct Pathol. 2002 Sep-Oct;26(5):331-4. doi: 10.1080/01913120290104610. Ultrastruct Pathol. 2002. PMID: 12396244

9

A novel atypical retinoid endowed with proapoptotic and antitumor activity.

Cincinelli R, Dallavalle S, Merlini L, Penco S, Pisano C, Carminati P, Giannini G, Vesci L, Gaetano C, Illy B, Zuco V, Supino R, Zunino F. Cincinelli R, et al. Among authors: zunino f. J Med Chem. 2003 Mar 13;46(6):909-12. doi: 10.1021/jm025593y. J Med Chem. 2003. PMID: 12620066

10

Antiangiogenic effects of the novel camptothecin ST1481 (gimatecan) in human tumor xenografts.

Petrangolini G, Pratesi G, De Cesare M, Supino R, Pisano C, Marcellini M, Giordano V, Laccabue D, Lanzi C, Zunino F. Petrangolini G, et al. Among authors: zunino f. Mol Cancer Res. 2003 Oct;1(12):863-70. Mol Cancer Res. 2003. PMID: 14573787

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

394 results

Search Page

Filters